Your browser doesn't support javascript.
loading
CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
Zheng, Rui; Li, Yueyan; Wang, Liren; Fang, Xiaoliang; Zhang, Junqi; He, Lei; Yang, Lei; Li, Dali; Geng, Hongquan.
Afiliación
  • Zheng R; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China.
  • Li Y; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China.
  • Wang L; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Fang X; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China.
  • Zhang J; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China.
  • He L; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China.
  • Yang L; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Li D; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: dlli@bio.ecnu.edu.cn.
  • Geng H; Department of Pediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Children's Stone Treatment Center of the National Health and Family Planning Commission of the People's Republic of China, Shanghai, China. Electronic address: genghongqu
Kidney Int ; 98(4): 947-957, 2020 10.
Article en En | MEDLINE | ID: mdl-32464217
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperoxaluria / Hiperoxaluria Primaria Límite: Animals Idioma: En Revista: Kidney Int Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperoxaluria / Hiperoxaluria Primaria Límite: Animals Idioma: En Revista: Kidney Int Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos